Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $240.55 | Total: $1,202.75 |
| 1 | 10 | $203.76 | Total: $2,037.60 |
| 1 | 25 | $172.63 | Total: $4,315.75 |
| 1 | 50 | $147.16 | Total: $7,358.00 |
| 1 | 100 | $127.35 | Total: $12,735.01 |
Overview
PQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
Chemical Properties
| Molecular Formula | C16H20F2N8O2 |
| Molecular Weight | 394.38 |
| CAS Numbers | 1927857-55-3 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | FC(F)C1=NC(=NC=C1C2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)N |
Storage and Handling
0C Short Term, -20C Long Term
References
Borsari C, et al. Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety. ACS Med Chem Lett. 2019 Sep 3;10[10] 1473-1479.